1983
DOI: 10.1038/302072a0
|View full text |Cite
|
Sign up to set email alerts
|

An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D

Abstract: Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) cause both persistent and latent infections, including recurrent cutaneous disease, lethal neonatal disease, central nervous system disease and other clinical syndromes. Modified live vaccines or conventionally prepared subunit vaccines have generally been unsuccessful in the treatment of HSV-1 and HSV-2 infections from the standpoints of safety and efficacy. It has been established that HSV-1 and HSV-2 infectivity may be neutralized in vitro with antisera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

1984
1984
1988
1988

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(14 citation statements)
references
References 18 publications
0
14
0
Order By: Relevance
“…The glycoprotein gD of HSV-1 has been shown to be a type-common antigen capable of inducing a host immune response which can protect against both HSV-1 and HSV-2 (10). For these reasons, the effort to produce a recombinant HSV vaccine by expression of a viral antigen in E. coli has centered on gD (44,45). The PRV gp50 has several similarities to HSV-1 gD.…”
Section: B) Discussionmentioning
confidence: 99%
“…The glycoprotein gD of HSV-1 has been shown to be a type-common antigen capable of inducing a host immune response which can protect against both HSV-1 and HSV-2 (10). For these reasons, the effort to produce a recombinant HSV vaccine by expression of a viral antigen in E. coli has centered on gD (44,45). The PRV gp50 has several similarities to HSV-1 gD.…”
Section: B) Discussionmentioning
confidence: 99%
“…It is known that herpesvirus glycoproteins are the principal antigens which induce host immune responses (Choppin & Scheid, 1980;Glorioso et al 1984;Norrild, 1980;Weis et al, 1983), and can be used as protective antigens for subunit vaccines (Ashley et al, 1985;Roberts et al, 1985). These observations encouraged us to try to prepare a vaccine for ADV.…”
Section: Protection Of Mice From Lethal Infection With Aujeszky's Dismentioning
confidence: 99%
“…In Escherichia coli, accumulation of abnormal or defective proteins into intracellular inclusion bodies and their subsequent proteolytic degradation have been described (25). Furthermore, since the advent of recombinant DNA technology, overexpression of foreign genes in E. coli has in many instances resulted in accumulation of the gene product into inclusion bodies (13,27,33,34,36). Naturally occurring paracrystalline inclusions have also been observed in several species of Thiobacillus (26) and in Micrococcus lysodeikticus (14).…”
Section: Discussionmentioning
confidence: 99%